Health
Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19) – News-Medical.Net
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to…
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.
The team’s SARS-BLOCK™ peptides competitively inhibit the receptor-binding domain (RBD) on the SARS-CoV-2 spike protein – the surface structure that binds the host cell angiotensin-converting enzyme 2 (ACE2) receptor, to…
-
General22 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News18 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News11 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General11 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final